Arrowhead Pharmaceuticals Inc (ARWR) — Strategic Asset Allocation Index
Arrowhead Pharmaceuticals Inc (ARWR) has a Strategic Asset Allocation Index of 116.9% as of September 2023. Strategic assets (PP&E of $335.56 Million plus long-term investments of $0.00) total $335.56 Million, measured against net assets of $287.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Arrowhead Pharmaceuticals Inc Strategic Asset Allocation Index (2003–2023)
This chart shows how Arrowhead Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 21 annual periods from 2003 to 2023. As of September 2023, the index stands at 116.9%, representing strategic assets of $335.56 Million against net assets of $287.16 Million USD. Explore Arrowhead Pharmaceuticals Inc cash conversion from operations to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Arrowhead Pharmaceuticals Inc (2003–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Arrowhead Pharmaceuticals Inc from 2003 to 2023, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see ARWR company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 218.8% | $628.29 Million | $335.56 Million | $292.74 Million | $287.16 Million | ▲ +167.1 pp |
| 2022 | 51.7% | $216.17 Million | $110.30 Million | $105.87 Million | $418.34 Million | ▼ -20.3 pp |
| 2021 | 72.0% | $294.27 Million | $48.67 Million | $245.59 Million | $408.82 Million | ▲ +35.5 pp |
| 2020 | 36.5% | $168.37 Million | $30.88 Million | $137.49 Million | $461.78 Million | ▲ +8.8 pp |
| 2019 | 27.6% | $67.39 Million | $23.21 Million | $44.18 Million | $244.04 Million | ▲ +13.0 pp |
| 2018 | 14.6% | $13.94 Million | $13.94 Million | $- | $95.24 Million | ▼ -4.6 pp |
| 2017 | 19.2% | $15.51 Million | $15.51 Million | $- | $80.87 Million | ▲ +3.0 pp |
| 2016 | 16.2% | $15.39 Million | $15.39 Million | $- | $95.02 Million | ▲ +12.1 pp |
| 2015 | 4.1% | $4.53 Million | $4.53 Million | $- | $109.62 Million | ▼ -12.1 pp |
| 2014 | 16.2% | $26.96 Million | $3.87 Million | $23.09 Million | $165.99 Million | ▲ +2.6 pp |
| 2013 | 13.7% | $3.51 Million | $3.51 Million | $- | $25.73 Million | ▼ -41.9 pp |
| 2012 | 55.6% | $4.90 Million | $4.90 Million | $- | $8.81 Million | ▲ +55.4 pp |
| 2011 | 0.2% | $25.44K | $25.44K | $- | $12.56 Million | ▼ -1.5 pp |
| 2010 | 1.7% | $141.00K | $141.00K | $- | $8.08 Million | ▼ -9.1 pp |
| 2009 | 10.8% | $527.00K | $527.00K | $- | $4.86 Million | ▲ +0.7 pp |
| 2008 | 10.1% | $1.25 Million | $1.25 Million | $- | $12.30 Million | ▲ +4.7 pp |
| 2007 | 5.4% | $1.44 Million | $1.44 Million | $- | $26.46 Million | ▲ +1.4 pp |
| 2006 | 4.0% | $1.27 Million | $1.27 Million | $- | $31.61 Million | ▲ +0.2 pp |
| 2005 | 3.8% | $1.08 Million | $1.08 Million | $- | $28.02 Million | ▼ -4.0 pp |
| 2004 | 7.9% | $882.00K | $882.00K | $- | $11.23 Million | ▲ +7.7 pp |
| 2003 | 0.1% | $2.00K | $2.00K | $- | $1.42 Million | — |